Nisidinasol (Paracetamol)

Paracetamol works by inhibiting cyclooxygenase enzymes in the central nervous system, which reduces the production of prostaglandins that signal pain and raise body temperature. This central action provides analgesic and antipyretic effects without significant peripheral anti‑inflammatory activity.

The appropriate dose of Nisidinasol is determined by a qualified prescriber based on the patient’s age, weight, clinical condition, and local regulatory guidelines. Patients should follow the healthcare professional’s instructions and never exceed the recommended amount.

Paracetamol is generally considered compatible with pregnancy and lactation when used at recommended doses, but safety depends on individual circumstances. Pregnant or breastfeeding individuals should consult their healthcare provider before using Nisidinasol to ensure it is appropriate for their situation.

To order Nisidinasol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Compared with non‑steroidal anti‑inflammatory drugs (NSAIDs), paracetamol offers analgesic and antipyretic benefits without the gastrointestinal or platelet‑inhibiting effects typical of NSAIDs. It is often preferred when anti‑inflammatory action is not required or when NSAID use is contraindicated.

Nisidinasol should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and excessive heat. Keep the product out of reach of children and avoid exposing it to direct sunlight.

Nisidinasol is taken orally, usually with a glass of water. The tablet (or other oral form) should be swallowed whole unless the prescribing information advises otherwise. It can be taken with or without food, depending on patient preference and tolerability.

The most serious risks include liver injury, especially with overdose or chronic high‑dose use, and rare severe skin reactions such as Stevens‑Johnson syndrome. Patients should avoid exceeding the recommended dose and seek immediate medical attention if they notice signs of liver dysfunction or severe rash.

Individuals with known hypersensitivity to paracetamol or any component of the formulation should avoid Nisidinasol. It should also be used with caution in patients with severe liver disease, chronic alcohol use, or those taking medications that significantly affect liver metabolism.